OBIO
Orchestra BioMed·NASDAQ
--
--(--)
--
--(--)
1.10 / 10
Underperform
OBIO's fundamental score is a low 1.1/10, indicating poor structural health. Key red flags include negative asset-to-market (-0.50) and revenue-to-market (-3.08) values, both in the weakest performance quartile. Net income-to-revenue is also negative (-0.17), and return on assets is deeply negative (-65.14%). Although interest coverage is adequate (15.48), it is insufficient to offset other deficits. Cash metrics (Cash-MV: -0.07) and Cash-UP: -0.06 further highlight liquidity strain. The consensus fundamental rating is Underperform, so investors should focus on cash-rich alternatives.
Analysis Checks(4/10)
Revenue-MV
Value-3.08
Score2/3
Weight-0.29%
1M Return0.09%
Value-3.08
Score2/3
Weight-0.29%
1M Return0.09%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight5.56%
1M Return-1.71%
Value100.00
Score2/3
Weight5.56%
1M Return-1.71%
Cash-UP
Value-0.06
Score2/3
Weight13.56%
1M Return-4.86%
Value-0.06
Score2/3
Weight13.56%
1M Return-4.86%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight6.27%
1M Return-1.95%
Value15.48
Score2/3
Weight6.27%
1M Return-1.95%
Cash-MV
Value-0.07
Score1/3
Weight14.90%
1M Return-5.64%
Value-0.07
Score1/3
Weight14.90%
1M Return-5.64%
ROA (%)
Value-65.14
Score0/3
Weight16.56%
1M Return-7.78%
Value-65.14
Score0/3
Weight16.56%
1M Return-7.78%
Net income-Revenue
Value-0.17
Score1/3
Weight7.85%
1M Return-2.55%
Value-0.17
Score1/3
Weight7.85%
1M Return-2.55%
Annualized net profit margin on total assets (%)
Value-86.85
Score0/3
Weight16.56%
1M Return-7.78%
Value-86.85
Score0/3
Weight16.56%
1M Return-7.78%
Asset-MV
Value-0.50
Score0/3
Weight10.51%
1M Return-3.57%
Value-0.50
Score0/3
Weight10.51%
1M Return-3.57%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight8.51%
1M Return-2.89%
Value100.00
Score1/3
Weight8.51%
1M Return-2.89%
Revenue-MV
Value-3.08
Score2/3
Weight-0.29%
1M Return0.09%
Value-3.08
Score2/3
Weight-0.29%
1M Return0.09%
ROA (%)
Value-65.14
Score0/3
Weight16.56%
1M Return-7.78%
Value-65.14
Score0/3
Weight16.56%
1M Return-7.78%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight5.56%
1M Return-1.71%
Value100.00
Score2/3
Weight5.56%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight7.85%
1M Return-2.55%
Value-0.17
Score1/3
Weight7.85%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight13.56%
1M Return-4.86%
Value-0.06
Score2/3
Weight13.56%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-86.85
Score0/3
Weight16.56%
1M Return-7.78%
Value-86.85
Score0/3
Weight16.56%
1M Return-7.78%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight6.27%
1M Return-1.95%
Value15.48
Score2/3
Weight6.27%
1M Return-1.95%
Asset-MV
Value-0.50
Score0/3
Weight10.51%
1M Return-3.57%
Value-0.50
Score0/3
Weight10.51%
1M Return-3.57%
Cash-MV
Value-0.07
Score1/3
Weight14.90%
1M Return-5.64%
Value-0.07
Score1/3
Weight14.90%
1M Return-5.64%
Net profit / Total profit (%)
Value100.00
Score1/3
Weight8.51%
1M Return-2.89%
Value100.00
Score1/3
Weight8.51%
1M Return-2.89%
Is OBIO undervalued or overvalued?
- OBIO scores 1.10/10 on fundamentals and holds a Premium valuation at present. Backed by its -153.71% ROE, -2665.05% net margin, -3.03 P/E ratio, 4.82 P/B ratio, and -12.50% earnings growth, these metrics solidify its Underperform investment rating.
